Hyponatremia
Welcome,         Profile    Billing    Logout  
 9 Companies   1 Product   1 Product   3 Mechanisms of Action   0 Trials   104 News 


12»
  • ||||||||||  tolvaptan / Generic mfg.
    Trial completion date, Trial termination, Trial primary completion date:  Tolvaptan for Patients With Acute Neurological Injuries (clinicaltrials.gov) -  Sep 24, 2018   
    P=N/A,  N=25, Terminated, 
    Trial completion date: Mar 2016 --> Jan 2017 Trial completion date: Sep 2017 --> Sep 2016 | Withdrawn --> Terminated | Trial primary completion date: Jul 2017 --> Jul 2016; Major protocol revision needed, current project terminated after enrollment of 25 patients.
  • ||||||||||  Enrollment change, Trial completion date, Trial withdrawal:  Protein Supplementation in Thiazide-induced Hyponatremia (clinicaltrials.gov) -  Sep 10, 2018   
    P=N/A,  N=0, Withdrawn, 
    Trial completion date: Sep 2017 --> Sep 2016 | Withdrawn --> Terminated | Trial primary completion date: Jul 2017 --> Jul 2016; Major protocol revision needed, current project terminated after enrollment of 25 patients. N=40 --> 0 | Trial completion date: Dec 2018 --> May 2018 | Recruiting --> Withdrawn
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  Beer for Endurance Exercise Recovery (clinicaltrials.gov) -  Apr 26, 2018   
    P=N/A,  N=43, Completed, 
    N=40 --> 0 | Trial completion date: Dec 2018 --> May 2018 | Recruiting --> Withdrawn Enrolling by invitation --> Completed | N=1000 --> 43 | Trial completion date: May 2019 --> May 2017 | Trial primary completion date: May 2019 --> May 2017
  • ||||||||||  tolvaptan / Generic mfg.
    Enrollment change, Trial withdrawal:  Tolvaptan for Patients With Acute Neurological Injuries (clinicaltrials.gov) -  Nov 20, 2017   
    P=N/A,  N=0, Withdrawn, 
    Recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 69 N=80 --> 0 | Recruiting --> Withdrawn
  • ||||||||||  Trial primary completion date:  Comparison of Infusion Methods for Hysteroscopic Procedures (clinicaltrials.gov) -  Feb 10, 2017   
    P=N/A,  N=100, Recruiting, 
    N=80 --> 58 | Recruiting --> Terminated | Trial primary completion date: Apr 2017 --> Jan 2017 Trial primary completion date: Dec 2016 --> Jun 2017
  • ||||||||||  New trial:  Beer for Endurance Exercise Recovery (clinicaltrials.gov) -  Jan 26, 2017   
    P=N/A,  N=1000, Enrolling by invitation, 
  • ||||||||||  tolvaptan / Generic mfg.
    Enrollment change, Trial termination:  Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients (clinicaltrials.gov) -  Sep 8, 2016   
    P=N/A,  N=1, Terminated, 
    Trial primary completion date: Nov 2016 --> Apr 2017 N=30 --> 1 | Recruiting --> Terminated; Slow subject enrollment and contracting issues; sponsor decided to abort study
  • ||||||||||  Enrollment change:  Comparison of Infusion Methods for Hysteroscopic Procedures (clinicaltrials.gov) -  Sep 7, 2016   
    P=N/A,  N=100, Recruiting, 
    N=30 --> 1 | Recruiting --> Terminated; Slow subject enrollment and contracting issues; sponsor decided to abort study N=40 --> 100
  • ||||||||||  Enrollment open, Trial initiation date, Trial primary completion date:  Protein Supplementation in Thiazide-induced Hyponatremia (clinicaltrials.gov) -  Jun 18, 2016   
    P=N/A,  N=40, Recruiting, 
    Trial primary completion date: Jun 2016 --> Sep 2016 Not yet recruiting --> Recruiting | Initiation date: Dec 2015 --> Jun 2016 | Trial primary completion date: Dec 2017 --> May 2018
  • ||||||||||  Trial primary completion date:  Comparison of Infusion Methods for Hysteroscopic Procedures (clinicaltrials.gov) -  Feb 24, 2016   
    P=N/A,  N=40, Recruiting, 
    N=80 --> 4 | Suspended --> Terminated | Trial primary completion date: Feb 2016 --> Jan 2014; Enrollment goals were not met. Trial primary completion date: Dec 2015 --> Dec 2016
  • ||||||||||  tolvaptan / Generic mfg.
    Enrollment change, Trial withdrawal, Trial primary completion date:  Fractional Urate Excretion in Nonedematous Hyponatremia (clinicaltrials.gov) -  Dec 12, 2015   
    P=N/A,  N=0, Withdrawn, 
    Initiation date: Sep 2015 --> Dec 2015 N=20 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Nov 2013 --> Dec 2014
  • ||||||||||  Trial completion, Trial primary completion date:  COMED Study: Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients (clinicaltrials.gov) -  Dec 5, 2015   
    P=N/A,  N=300, Completed, 
    N=20 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Nov 2013 --> Dec 2014 Active, not recruiting --> Completed | Trial primary completion date: Aug 2015 --> Apr 2015
  • ||||||||||  tolvaptan / Generic mfg.
    Trial primary completion date:  Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients (clinicaltrials.gov) -  Dec 4, 2015   
    P=N/A,  N=30, Recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Aug 2015 --> Apr 2015 Trial primary completion date: Apr 2016 --> Aug 2016
  • ||||||||||  Preclinical, Enrollment change, Trial termination, Trial primary completion date:  Hyponatremia and Myometrium Contractility. An Invitro Study (clinicaltrials.gov) -  Oct 23, 2015   
    P=N/A,  N=12, Terminated, 
    Not yet recruiting --> Enrolling by invitation N=30 --> 12 | Recruiting --> Terminated | Trial primary completion date: Mar 2014 --> Oct 2015; Few biopsies showed the expected pattern We suspect erroeneous method.
  • ||||||||||  ibuprofen / Generic mfg.
    Enrollment open, Trial primary completion date:  NAKED: Non-steroidal Anti-inflammatory Affect on Kidneys in Endurance Distances (clinicaltrials.gov) -  Aug 28, 2015   
    P3,  N=120, Recruiting, 
    N=30 --> 12 | Recruiting --> Terminated | Trial primary completion date: Mar 2014 --> Oct 2015; Few biopsies showed the expected pattern We suspect erroeneous method. Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2015 --> Mar 2016
  • ||||||||||  Enrollment change, Trial initiation date, Trial withdrawal:  Frequency and Origin of Dysnatremias in the Emergency Department (clinicaltrials.gov) -  Aug 12, 2015   
    P=N/A,  N=0, Withdrawn, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2015 --> Mar 2016 N=200 --> 0 | Initiation date: Aug 2012 --> Oct 2011 | Not yet recruiting --> Withdrawn
  • ||||||||||  tolvaptan / Generic mfg.
    Trial completion, Phase classification, Enrollment change, Trial primary completion date:  OASIS: Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia (clinicaltrials.gov) -  Aug 11, 2015   
    P3,  N=98, Completed, 
    N=200 --> 0 | Initiation date: Aug 2012 --> Oct 2011 | Not yet recruiting --> Withdrawn Recruiting --> Completed | Phase classification: PN/A --> P3 | N=296 --> 98 | Trial primary completion date: Nov 2013 --> Sep 2014
  • ||||||||||  tolvaptan / Generic mfg.
    Enrollment change, Trial termination:  Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia (clinicaltrials.gov) -  Jul 20, 2015   
    P4,  N=2, Terminated, 
    Recruiting --> Completed | Phase classification: PN/A --> P3 | N=296 --> 98 | Trial primary completion date: Nov 2013 --> Sep 2014 N=20 --> 2 | Recruiting --> Terminated